Cryo-Cell International, Inc. (CCEL)
USD 7.65
(-4.26%)
USD 7.65
(-4.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 9.28 Million USD | 4.37% |
| 2022 | 8.89 Million USD | 1355.54% |
| 2021 | 610.98 Thousand USD | -78.67% |
| 2020 | 2.86 Million USD | -51.08% |
| 2019 | 5.85 Million USD | -40.51% |
| 2018 | 9.84 Million USD | 85.9% |
| 2017 | 5.29 Million USD | -32.28% |
| 2016 | 7.81 Million USD | 799.91% |
| 2015 | 868.94 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 2.3 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 286.44 Thousand USD | -25.18% |
| 2008 | 382.84 Thousand USD | 105.72% |
| 2007 | -6.69 Million USD | -13.99% |
| 2006 | -5.87 Million USD | -31.81% |
| 2005 | -4.45 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 7579.00 USD | -47.84% |
| 2000 | 14.53 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 9.16 Million USD | -0.45% |
| 2024 Q3 | 8.33 Million USD | -0.31% |
| 2024 Q2 | 9.02 Million USD | -0.42% |
| 2023 FY | 9.28 Million USD | 4.37% |
| 2023 Q2 | 9.47 Million USD | 7.77% |
| 2023 Q4 | 9.28 Million USD | -1.03% |
| 2023 Q1 | 8.78 Million USD | -1.16% |
| 2023 Q3 | 9.37 Million USD | -1.0% |
| 2022 Q4 | 8.89 Million USD | -1.11% |
| 2022 Q3 | 8.99 Million USD | 1880.97% |
| 2022 Q1 | 530.94 Thousand USD | -13.1% |
| 2022 Q2 | 453.97 Thousand USD | -14.5% |
| 2022 FY | 8.89 Million USD | 1355.54% |
| 2021 Q3 | 690.34 Thousand USD | -36.97% |
| 2021 FY | 610.98 Thousand USD | -78.67% |
| 2021 Q1 | 1.86 Million USD | -35.06% |
| 2021 Q2 | 1.09 Million USD | -41.12% |
| 2021 Q4 | 610.98 Thousand USD | -11.5% |
| 2020 Q1 | 5.33 Million USD | -8.86% |
| 2020 Q2 | 4.51 Million USD | -15.38% |
| 2020 Q3 | 3.69 Million USD | -18.25% |
| 2020 Q4 | 2.86 Million USD | -22.41% |
| 2020 FY | 2.86 Million USD | -51.08% |
| 2019 Q1 | 9.09 Million USD | -7.57% |
| 2019 Q2 | 8.35 Million USD | -8.21% |
| 2019 FY | 5.85 Million USD | -40.51% |
| 2019 Q3 | 6.6 Million USD | -20.92% |
| 2019 Q4 | 5.85 Million USD | -11.33% |
| 2018 Q4 | 9.84 Million USD | -15.06% |
| 2018 FY | 9.84 Million USD | 85.9% |
| 2018 Q3 | 11.58 Million USD | 166.62% |
| 2018 Q2 | 4.34 Million USD | -9.85% |
| 2018 Q1 | 4.82 Million USD | -8.94% |
| 2017 Q4 | 5.29 Million USD | -8.18% |
| 2017 FY | 5.29 Million USD | -32.28% |
| 2017 Q1 | 7.35 Million USD | -5.96% |
| 2017 Q2 | 6.88 Million USD | -6.36% |
| 2017 Q3 | 5.76 Million USD | -16.26% |
| 2016 Q4 | 7.81 Million USD | -9.6% |
| 2016 Q2 | 650.1 Thousand USD | -17.81% |
| 2016 FY | 7.81 Million USD | 799.91% |
| 2016 Q3 | 8.65 Million USD | 1230.58% |
| 2016 Q1 | 790.95 Thousand USD | -8.98% |
| 2015 Q4 | 868.94 Thousand USD | -8.27% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | 947.24 Thousand USD | 0.0% |
| 2015 FY | 868.94 Thousand USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q2 | - USD | -100.0% |
| 2012 Q3 | 2.3 Million USD | 0.0% |
| 2012 Q1 | 2.85 Million USD | 0.0% |
| 2012 FY | 2.3 Million USD | 0.0% |
| 2012 Q4 | 2.3 Million USD | 0.0% |
| 2011 Q4 | 2.85 Million USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q2 | 235.65 Thousand USD | -10.47% |
| 2010 FY | - USD | -100.0% |
| 2010 Q1 | 263.21 Thousand USD | -8.11% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 211.6 Thousand USD | -10.2% |
| 2009 Q2 | 335.48 Thousand USD | -7.12% |
| 2009 Q3 | 313.06 Thousand USD | -6.69% |
| 2009 Q4 | 286.44 Thousand USD | -8.5% |
| 2009 FY | 286.44 Thousand USD | -25.18% |
| 2009 Q1 | 361.19 Thousand USD | -5.66% |
| 2008 Q4 | 382.84 Thousand USD | 105.49% |
| 2008 Q3 | -6.97 Million USD | 0.0% |
| 2008 FY | 382.84 Thousand USD | 105.72% |
| 2008 Q1 | -6.71 Million USD | 0.0% |
| 2008 Q2 | - USD | 100.0% |
| 2007 Q4 | - USD | 100.0% |
| 2007 FY | -6.69 Million USD | -13.99% |
| 2007 Q3 | -6.53 Million USD | 0.0% |
| 2007 Q2 | - USD | 100.0% |
| 2007 Q1 | -6.21 Million USD | -5.75% |
| 2006 FY | -5.87 Million USD | -31.81% |
| 2006 Q1 | -4.88 Million USD | -9.51% |
| 2006 Q3 | -5.86 Million USD | -11.99% |
| 2006 Q4 | -5.87 Million USD | -0.13% |
| 2006 Q2 | -5.23 Million USD | -7.34% |
| 2005 Q1 | - USD | 100.0% |
| 2005 FY | -4.45 Million USD | 0.0% |
| 2005 Q4 | -4.45 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q4 | -3.02 Million USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 FY | - USD | -100.0% |
| 2002 Q4 | - USD | -100.0% |
| 2002 Q2 | 3785.00 USD | -77.64% |
| 2002 Q3 | 2208.00 USD | -41.66% |
| 2002 Q1 | 16.92 Thousand USD | 123.31% |
| 2001 FY | 7579.00 USD | -47.84% |
| 2001 Q1 | 12.86 Thousand USD | -11.44% |
| 2001 Q2 | 11.15 Thousand USD | -13.3% |
| 2001 Q4 | 7579.00 USD | -19.32% |
| 2001 Q3 | 9394.00 USD | -15.79% |
| 2000 Q2 | - USD | -100.0% |
| 2000 FY | 14.53 Thousand USD | 0.0% |
| 2000 Q1 | 16.29 Thousand USD | 0.0% |
| 2000 Q3 | 13 Thousand USD | 0.0% |
| 2000 Q4 | 14.53 Thousand USD | 11.76% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 99.309% |
| Addus HomeCare Corporation | 124.13 Million USD | 92.522% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | 86.645% |
| Amedisys, Inc. | 346.76 Million USD | 97.323% |
| American Oncology Network, Inc. | 120.44 Million USD | 92.294% |
| Astrana Health, Inc. | 296.26 Million USD | 96.867% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 99.273% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | 91.295% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -248.553% |
| COMPASS Pathways plc | 28.75 Million USD | 67.723% |
| DocGo Inc. | 15.16 Million USD | 38.781% |
| The Ensign Group, Inc. | 1.78 Billion USD | 99.48% |
| Healthcare Services Group, Inc. | 11.23 Million USD | 17.383% |
| InnovAge Holding Corp. | 100.49 Million USD | 90.764% |
| Assure Holdings Corp. | 505 Thousand USD | -1738.015% |
| The Joint Corp. | 2 Million USD | -364.099% |
| LifeStance Health Group, Inc. | 280.28 Million USD | 96.688% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -2333.41% |
| ModivCare Inc. | 983.75 Million USD | 99.056% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -7701.356% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -427.8% |
| Option Care Health, Inc. | 1.05 Billion USD | 99.122% |
| P3 Health Partners Inc. | 108.31 Million USD | 91.431% |
| P3 Health Partners Inc. | 108.31 Million USD | 91.431% |
| The Pennant Group, Inc. | 312.51 Million USD | 97.03% |
| Surgery Partners, Inc. | 2.03 Billion USD | 99.544% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | 89.31% |
| The Oncology Institute, Inc. | 86.82 Million USD | 89.31% |